@article{article_417314, title={Skin necrosis: An uncommon side effect of warfarin therapy}, journal={Ege Tıp Dergisi}, volume={58}, pages={190–191}, year={2019}, DOI={10.19161/etd.417314}, url={https://izlik.org/JA45CL55DE}, author={Devrim, Tuba and Demirkan, Serkan}, keywords={Varfarin,deri nekrozu,antikoagülanlar,tedavi komplikasyonu.}, abstract={<p class="MsoNormal" style="margin-top:2pt;margin-right:0cm;margin-bottom:3pt;margin-left:0cm;text-align:justify;line-height:12.3pt;"> <span lang="en-us" style="font-size:9pt;font-family:Arial, ’sans-serif’;" xml:lang="en-us">Warfarin
is commonly used in the treatment and prevention of thromboembolic events.
However, it is known to undesirably cause hypercoagulable conditions, including
warfarin-induced skin necrosis (WISN). This report describes <span>a 70-year-old man presented with an
extensive WISN while an inpatient for treatment of a </span>left deep femoral
vein thrombosis <span>. He had a background
of </span>colon adenocarcinoma and multiple metastatic foci in the liver <span>.  </span> </span> </p> <p> </p>}, number={2}